(Approval lapsed) Dobutamine 12.5 mg/mL (250mg/20mL) concentrate for solution for infusion ampoule
Section 19A approved medicine
(Approval lapsed) Dobutamine 12.5 mg/mL (250mg/20mL) concentrate for solution for infusion ampoule
Section 19A approval holder
Link Medical Products Pty Ltd ABN 73 010 971 516
Phone
1800 181 060
Approved until
Status
Expired
Medicines in short supply/unavailable
DBL DOBUTAMINE 250mg/20mL (as hydrochloride) injection vial - ARTG 46451
Indication(s)
Adults who require short-term treatment of cardiac failure secondary to acute myocardial infarction, or cardiac surgery